Marita Zuraitis sold $1.6M of HMN
President & CEO at HORACE MANN EDUCATORS CORP /DE/. 42,117 shares at an average of $37.06, traded Oct 17, 2024, filed Oct 21, 2024.
Score components
- +25RoleCEO
- +25Trade size$1.6M at market
- +5Share of holdings soldSold 14% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.1%, 3m +5.0%, 6m +7.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-24-017733, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -16,000 | $37.00 | $592k | 294,402 | Oct 21, 2024 |
| Oct 17, 2024 | MOption exercise Common Stock10b5-1 | +24,677 | $32.35 | $798k | 319,079 | Oct 21, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -24,677 | $37.10 | $915k | 294,402 | Oct 21, 2024 |
| Oct 17, 2024 | MOption exercise Common Stock10b5-1 | +1,440 | $32.35 | $47k | 295,842 | Oct 21, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -1,440 | $37.09 | $53k | 294,402 | Oct 21, 2024 |
| Oct 18, 2024 | MOption exercise Common Stock10b5-1 | +1,828 | $32.35 | $59k | 296,230 | Oct 21, 2024 |
| Oct 18, 2024 | MOption exercise Common Stock10b5-1 | +106 | $32.35 | $3,429 | 296,336 | Oct 21, 2024 |
| Oct 17, 2024 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -24,677 | $0.00 | $0 | 1,828 | Oct 21, 2024 |
| Oct 17, 2024 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,440 | $0.00 | $0 | 106 | Oct 21, 2024 |
| Oct 18, 2024 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,828 | $0.00 | $0 | 0 | Oct 21, 2024 |
| Oct 18, 2024 | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -106 | $0.00 | $0 | 0 | Oct 21, 2024 |
Related signals
Other insiders at HORACE MANN EDUCATORS CORP /DE/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | HORACE MANN EDUCATORS CORP /DE/ | Marita Zuraitis President & CEO | $4,600 100 shares | -0% | |
| 40Moderate | HORACE MANN EDUCATORS CORP /DE/ | Donald M Carley General Counsel | $107k 2,054 shares | -7% | |
| 46Moderate | HORACE MANN EDUCATORS CORP /DE/ | Perry G. Hines director | $169k 3,237 shares | -11% | |
| 36Weak | HORACE MANN EDUCATORS CORP /DE/ | Marita Zuraitis President & CEO | $382k 7,500 shares | -2% | |
| 31Weak | HMNsell HORACE MANN EDUCATORS CORP /DE/ | Donald M Carley General Counsel | $161k 3,500 shares | -14% | |
| 20Weak | HORACE MANN EDUCATORS CORP /DE/ | Bret A Conklin Executive Vice President | $204k 4,760 shares | -8% | |
| 31Weak | HORACE MANN EDUCATORS CORP /DE/ | Bret A Conklin Executive Vice President | $487k 11,238 shares | -19% | |
| 32Weak | HORACE MANN EDUCATORS CORP /DE/ | Marita Zuraitis President & CEO | $216k 5,000 shares | -2% | |
| 36Weak | HORACE MANN EDUCATORS CORP /DE/ | Bret A Conklin Executive Vice President | $407k 9,435 shares | -15% | |
| 48Moderate | HORACE MANN EDUCATORS CORP /DE/ | Bret A Conklin Executive Vice President | $878k 20,200 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.